Sunny Pharmtech Inc. - Laporan Laba Rugi (TTM)

Sunny Pharmtech Inc.
TW ˙ TPEX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Sunny Pharmtech Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
Revenue 426 420 366 312 277 241 257 274 317 360 371 382 405 429 457 485 452 418
Change (%) -1.45 -12.82 -14.71 -11.41 -12.88 6.81 6.38 15.66 13.54 3.06 2.97 6.19 5.83 6.55 6.15 -6.91 -7.42
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 214 196 170 145 135 125 135 145 149 153 137 120 132 143 174 204 198 192
Change (%) -8.44 -12.97 -14.90 -6.83 -7.33 8.00 7.41 2.61 2.55 -10.70 -11.99 9.63 8.79 21.11 17.43 -2.99 -3.09
% of Revenue 50.20 46.64 46.56 46.46 48.86 51.97 52.55 53.05 47.07 42.52 36.84 31.49 32.51 33.42 37.98 42.02 43.79 45.84
Gross Operating Profit 212 224 196 167 141 116 122 129 168 207 234 261 273 286 283 281 254 226
Change (%) 5.58 -12.69 -14.54 -15.39 -18.18 5.53 5.24 30.39 23.31 13.23 11.69 4.61 4.41 -0.76 -0.76 -9.74 -10.80
% of Revenue 49.80 53.36 53.44 53.54 51.14 48.03 47.45 46.95 52.93 57.48 63.16 68.51 67.49 66.58 62.02 57.98 56.21 54.16
SG&A 114 116 115 113 117 120 127 133 136 138 142 145 147 149 151 153 162 170
Change (%) 2.46 -1.51 -1.53 3.34 3.23 5.29 5.02 2.00 1.96 2.30 2.25 1.36 1.34 1.52 1.50 5.49 5.21
% of Revenue 26.65 27.71 31.31 36.14 42.16 49.95 49.24 48.61 42.87 38.50 38.22 37.95 36.23 34.69 33.05 31.60 35.81 40.70
R&D 187 182 180 178 175 171 184 197 226 256 248 240 224 209 202 195 207 219
Change (%) -2.69 -0.99 -1.00 -1.98 -2.02 7.45 6.94 14.97 13.02 -3.18 -3.29 -6.41 -6.85 -3.22 -3.33 6.11 5.76
% of Revenue 43.90 43.35 49.23 57.14 63.22 71.11 71.53 71.91 71.48 71.16 66.85 62.79 55.34 48.71 44.24 40.29 45.92 52.46
OpEx 515 494 465 436 427 417 446 475 511 547 526 505 503 501 527 552 567 581
Change (%) -3.94 -5.86 -6.23 -2.22 -2.27 6.99 6.53 7.56 7.03 -3.90 -4.06 -0.36 -0.36 5.15 4.89 2.58 2.52
% of Revenue 120.75 117.70 127.10 139.74 154.24 173.03 173.32 173.57 161.43 152.18 141.91 132.23 124.07 116.81 115.27 113.91 125.52 138.99
Operating Income -88 -74 -99 -124 -150 -176 -189 -201 -195 -188 -155 -123 -98 -72 -70 -67 -115 -163
Change (%) -15.93 33.45 25.07 20.92 17.30 7.23 6.75 -3.44 -3.56 -17.23 -20.81 -20.69 -26.09 -3.21 -3.31 70.78 41.44
% of Revenue -20.75 -17.70 -27.10 -39.74 -54.24 -73.03 -73.32 -73.57 -61.43 -52.18 -41.91 -32.23 -24.07 -16.81 -15.27 -13.91 -25.52 -38.99
Interest Expense -7 -7 -6 -6 -6 -6 -6 -6 -5 -5 -6 -7 -9 -11 -10 -9 -9 -9
Change (%) -5.95 -6.45 -6.89 -2.49 -2.56 6.39 6.01 -13.85 -16.08 29.39 22.72 27.18 21.37 -7.99 -8.69 -1.99 -2.03
% of Revenue -1.70 -1.62 -1.74 -1.90 -2.09 -2.33 -2.32 -2.32 -1.73 -1.28 -1.60 -1.91 -2.29 -2.62 -2.26 -1.95 -2.05 -2.17
Net Income -112 -102 -126 -150 -162 -175 -179 -182 -176 -170 -143 -116 -90 -63 -57 -50 -103 -156
Change (%) -8.80 23.70 19.16 8.26 7.63 2.13 2.08 -3.29 -3.40 -15.94 -18.96 -22.70 -29.37 -10.14 -11.28 104.52 51.11
% of Revenue -26.18 -24.23 -34.38 -48.04 -58.70 -72.53 -69.35 -66.54 -55.64 -47.34 -38.62 -30.40 -22.13 -14.77 -12.45 -10.41 -22.87 -37.32

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista